BioAtla
cab dosing regimens under evaluation | BioAtla
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
49 of 55
Similar slides by BioAtla
See diffirences between slides (animation)
Investor Presentation
August 2023
dosing regimens under evaluation for cab | BioAtla
Investor Presentation
August 2023
dosing regimens under evaluation for cab | BioAtla
Investor Presentation
May 2023
dosing regimens under evaluation for cab | BioAtla
Investor Presentation
May 2023
dosing regimens under evaluation for cab | BioAtla
Related slides by other companies
Alkermes
Results
October 2023
single dose time course suggests a therapeutic dose between and in | Alkermes
GH Research
Investor Presentation
March 2023
and observed improved outcome in phase phase single dose | GH Research
DICE Therapeutics
Investor Presentation
March 2023
profile of supports commercially viable dosing one pill once a day to cover one pill twice a day to cover dice | DICE Therapeutics
Fusion Pharmaceuticals
Investor Presentation
November 2023
development program are | Fusion Pharmaceuticals
Other recent decks by BioAtla
See all presentations (8 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Investor Presentation
November 2022
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io